RhumbLine Advisers’s National Healthcare NHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.48M | Sell |
34,311
-4,765
| -12% | -$731K | ﹤0.01% | 1360 |
|
|
2025
Q4 | $5.36M | Sell |
39,076
-3,171
| -8% | -$410K | ﹤0.01% | 1365 |
|
|
2025
Q3 | $5.13M | Sell |
42,247
-4,031
| -9% | -$435K | ﹤0.01% | 1430 |
|
|
2025
Q2 | $4.95M | Buy |
46,278
+1,232
| +3% | +$123K | ﹤0.01% | 1420 |
|
|
2025
Q1 | $4.18M | Buy |
45,046
+1,377
| +3% | +$133K | ﹤0.01% | 1450 |
|
|
2024
Q4 | $4.7M | Sell |
43,669
-1,022
| -2% | -$124K | ﹤0.01% | 1448 |
|
|
2024
Q3 | $5.62M | Sell |
44,691
-4,930
| -10% | -$620K | 0.01% | 1364 |
|
|
2024
Q2 | $5.38M | Sell |
49,621
-750
| -1% | -$73.1K | 0.01% | 1358 |
|
|
2024
Q1 | $4.76M | Sell |
50,371
-9,559
| -16% | -$905K | ﹤0.01% | 1443 |
|
|
2023
Q4 | $5.54M | Buy |
59,930
+20,375
| +52% | +$1.56M | 0.01% | 1353 |
|
|
2023
Q3 | $2.53M | Sell |
39,555
-306
| -0.8% | -$19.6K | ﹤0.01% | 1747 |
|
|
2023
Q2 | $2.46M | Buy |
39,861
+751
| +2% | +$44.5K | ﹤0.01% | 1792 |
|
|
2023
Q1 | $2.27M | Buy |
39,110
+322
| +0.8% | +$18.5K | ﹤0.01% | 1734 |
|
|
2022
Q4 | $2.31M | Buy |
38,788
+268
| +0.7% | +$16.2K | ﹤0.01% | 1707 |
|
|
2022
Q3 | $2.44M | Buy |
38,520
+1,443
| +4% | +$100K | ﹤0.01% | 1646 |
|
|
2022
Q2 | $2.59M | Buy |
37,077
+841
| +2% | +$58.9K | ﹤0.01% | 1632 |
|
|
2022
Q1 | $2.54M | Sell |
36,236
-1,096
| -3% | -$73.7K | ﹤0.01% | 1691 |
|
|
2021
Q4 | $2.54M | Sell |
37,332
-218
| -0.6% | -$15.1K | ﹤0.01% | 1746 |
|
|
2021
Q3 | $2.63M | Buy |
37,550
+19,150
| +104% | +$1.39M | ﹤0.01% | 1741 |
|
|
2021
Q2 | $1.29M | Sell |
18,400
-2,400
| -12% | -$174K | ﹤0.01% | 2138 |
|
|
2021
Q1 | $1.62M | Sell |
20,800
-1,231
| -6% | -$87.1K | ﹤0.01% | 1996 |
|
|
2020
Q4 | $1.46M | Buy |
22,031
+2,676
| +14% | +$176K | ﹤0.01% | 1989 |
|
|
2020
Q3 | $1.21M | Sell |
19,355
-33,615
| -63% | -$2.1M | ﹤0.01% | 1916 |
|
|
2020
Q2 | $3.36M | Buy |
52,970
+1,749
| +3% | +$117K | 0.01% | 1435 |
|
|
2020
Q1 | $3.67M | Buy |
51,221
+10,148
| +25% | +$803K | 0.01% | 1219 |
|
|
2019
Q4 | $3.55M | Buy |
41,073
+335
| +0.8% | +$28K | 0.01% | 1468 |
|
|
2019
Q3 | $3.33M | Buy |
40,738
+10,684
| +36% | +$885K | 0.01% | 1415 |
|
|
2019
Q2 | $2.44M | Buy |
30,054
+3,002
| +11% | +$232K | ﹤0.01% | 1612 |
|
|
2019
Q1 | $2.05M | Sell |
27,052
-6,333
| -19% | -$502K | ﹤0.01% | 1693 |
|
|
2018
Q4 | $2.62M | Buy |
33,385
+5,148
| +18% | +$403K | 0.01% | 1485 |
|
|
2018
Q3 | $2.13M | Buy |
28,237
+15,834
| +128% | +$1.17M | ﹤0.01% | 1621 |
|
|
2018
Q2 | $873K | Buy |
12,403
+775
| +7% | +$50.7K | ﹤0.01% | 2066 |
|
|
2018
Q1 | $693K | Sell |
11,628
-675
| -5% | -$41.4K | ﹤0.01% | 2092 |
|
|
2017
Q4 | $750K | Sell |
12,303
-3,026
| -20% | -$193K | ﹤0.01% | 2075 |
|
|
2017
Q3 | $959K | Sell |
15,329
-10,287
| -40% | -$663K | ﹤0.01% | 2001 |
|
|
2017
Q2 | $1.8M | Sell |
25,616
-310
| -1% | -$22.1K | ﹤0.01% | 1651 |
|
|
2017
Q1 | $1.85M | Buy |
25,926
+11,680
| +82% | +$864K | ﹤0.01% | 1596 |
|
|
2016
Q4 | $1.08M | Sell |
14,246
-1,329
| -9% | -$92.1K | ﹤0.01% | 1811 |
|
|
2016
Q3 | $1.03M | Buy |
15,575
+1,634
| +12% | +$106K | ﹤0.01% | 1785 |
|
|
2016
Q2 | $903K | Sell |
13,941
-3,159
| -18% | -$201K | ﹤0.01% | 1847 |
|
|
2016
Q1 | $1.06M | Buy |
17,100
+1,870
| +12% | +$116K | ﹤0.01% | 1747 |
|
|
2015
Q4 | $940K | Sell |
15,230
-220
| -1% | -$14.3K | ﹤0.01% | 1843 |
|
|
2015
Q3 | $941K | Buy |
15,450
+841
| +6% | +$52.6K | ﹤0.01% | 1800 |
|
|
2015
Q2 | $949K | Sell |
14,609
-980
| -6% | -$62.2K | ﹤0.01% | 1897 |
|
|
2015
Q1 | $993K | Buy |
15,589
+800
| +5% | +$50.8K | ﹤0.01% | 1861 |
|
|
2014
Q4 | $929K | Buy |
14,789
+1,025
| +7% | +$61.6K | ﹤0.01% | 1866 |
|
|
2014
Q3 | $764K | Buy |
13,764
+400
| +3% | +$22.6K | ﹤0.01% | 1932 |
|
|
2014
Q2 | $752K | Sell |
13,364
-1,070
| -7% | -$58.3K | ﹤0.01% | 2014 |
|
|
2014
Q1 | $805K | Sell |
14,434
-520
| -3% | -$27.3K | ﹤0.01% | 1931 |
|
|
2013
Q4 | $806K | Sell |
14,954
-900
| -6% | -$46K | ﹤0.01% | 1960 |
|
|
2013
Q3 | $749K | Sell |
15,854
-12,951
| -45% | -$619K | ﹤0.01% | 1958 |
|
|
2013
Q2 | $1.38M | Buy |
+28,805
| New | +$1.34M | ﹤0.01% | 1554 |
|
Other funds holding NHC
MSIIA
VPM
VCM
MHS
RhumbLine Advisers's NHC Position: Q1 2026 in Review
RhumbLine Advisers reduced its National Healthcare (NHC) stake by 12% in Q1 2026, selling an estimated $731K and leaving 34,311 shares worth $5.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1360.
RhumbLine Advisers first reported a position in NHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.62M in Q3 2024. 238 funds tracked by Wall St. Rank hold NHC as of Q1 2026.
- RhumbLine Advisers held 34,311 shares of National Healthcare worth $5.48M as of Q1 2026.
- RhumbLine Advisers sold 4,765 National Healthcare shares in Q1 2026, an estimated $731K.
- National Healthcare made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #1360 holding.
- RhumbLine Advisers first reported a position in National Healthcare in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's National Healthcare position peaked at $5.62M in Q3 2024.
- 238 funds tracked by Wall St. Rank held National Healthcare as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.